Entrada Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.9 | $0.9 | $1.6 | $2 | $21 | $20 | $95 | $59 | |
| −$43 | −$40 | −$44 | −$43 | −$17 | −$14 | $55 | $23 | |
| −$1.01 | −$0.95 | −$1.06 | −$1.04 | −$0.42 | −$0.35 | $1.55 | $0.68 | |
| 42 | 42 | 41 | 41 | 41 | 41 | 36 | 35 |
Trend